Emil Chuang
Direttore Tecnico/Scientifico/R&S presso Intrinsic Medicine, Inc.
Profilo
Emil Chuang is currently the Chief Medical Officer at Intrinsic Medicine, Inc. He previously held the same position at the same company.
Prior to that, he was the Global Head-Translational Research at Takeda Pharmaceutical Co., Ltd.
from 2016 to 2018.
From 2018 to 2020, he was the Vice President-Precision Medicine at Biora Therapeutics, Inc. Chuang completed his undergraduate degree at The University of Sydney.
Posizioni attive di Emil Chuang
| Società | Posizione | Inizio |
|---|---|---|
Intrinsic Medicine, Inc.
 Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Direttore Tecnico/Scientifico/R&S | 01/09/2021 |
Precedenti posizioni note di Emil Chuang
| Società | Posizione | Fine |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2020 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/06/2018 |
Formazione di Emil Chuang
| The University of Sydney | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIORA THERAPEUTICS, INC. | Health Services |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Intrinsic Medicine, Inc.
Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Commercial Services |
- Borsa valori
- Insiders
- Emil Chuang
